ERAXIS
ERAXIS
Approved
DIN Number
02330695
Drug Class
Human
Market Date
Jan 25, 2010
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02330695
AIG Number0152373001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AX06 ANIDULAFUNGIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:14.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANIDULAFUNGINActive
Strength: 100 MG / VIAL
Monograph: ANIDULAFUNGIN